Jim Simons Medicenna Therapeutics Corp. Transaction History

Renaissance Technologies LLC

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$0.28 - $0.51 $1,480 - $2,696	-5,287 Reduced 5.85%	85,113 $25,000
Q2 2023 Aug 11, 2023	SELL	$0.44 - $0.82 $26,356 - $49,118	-59,900 Reduced 39.85%	90,400 $44,000
Q1 2023 May 12, 2023	SELL	$0.5 - $0.78 $13,121 - $20,468	-26,242 Reduced 14.86%	150,300 $95,000
Q4 2022 Feb 13, 2023	BUY	$0.4 - $0.68 $52,456 - $89,176	131,142 Added 288.86%	176,542 $81,000
Q3 2022 Nov 14, 2022	BUY	$0.83 - $1.78 $11,039 - $23,674	13,300 Added 41.43%	45,400 $38,000
Q2 2022 Aug 12, 2022	SELL	$0.79 - $1.32 $6,004 - $10,032	-7,600 Reduced 19.14%	32,100 $37,000
Q1 2022 May 13, 2022	SELL	$1.26 - $1.92 $74,718 - $113,856	-59,300 Reduced 59.9%	39,700 $51,000
Q4 2021 Feb 11, 2022	BUY	$1.53 - $2.85 $133,263 - $248,235	87,100 Added 731.93%	99,000 $161,000
Q3 2021 Nov 12, 2021	SELL	$1.91 - $3.05 $39,242 - $62,665	-20,546 Reduced 63.32%	11,900 $33,000
Q2 2021 Aug 13, 2021	SELL	$2.97 - $4.28 $322,999 - $465,467	-108,754 Reduced 77.02%	32,446 $98,000
Q1 2021 May 13, 2021	BUY	$3.5 - $4.56 $37,450 - $48,791	10,700 Added 8.2%	141,200 $574,000
Q4 2020 Feb 10, 2021	SELL	$3.7 - $5.97 $367,780 - $593,418	-99,400 Reduced 43.24%	130,500 $608,000
Q3 2020 Nov 13, 2020	BUY	$3.55 - $4.67 $816,145 - $1.07 Million	229,900 New	229,900 $945,000

863K

Ticker MDNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 69,637,504
Market Cap $21.6M
Description
Medicenna Therapeutics Corp., an immunotherapy company, engages in the development and commercialization of Superkines and empowered Superkines for the treatment of cancer and other diseases. Its lead product is MDNA55, an interleukin- 4 (IL-4) EC that has completed Phase IIb clinical trial for the treatment of recurrent glioblastoma, as well as...

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.